Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and Rituximab
Clinical trial NCT01416974 · COMPLETED
Trial details
- NCT number
- NCT01416974
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-22
- Primary completion
- 2019-01-07
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.